Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitsias, P. D.
Right arrow Articles by Chopp, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitsias, P. D.
Right arrow Articles by Chopp, M.
Related Collections
Right arrow All Clinical trials
Right arrow All Cerebrovascular disease/Stroke
Right arrow Clinical trials Observational study (Cohort, Case control)
Right arrow Infarction
Right arrowRelated Article
NEUROLOGY 2005;65:612-615
© 2005 American Academy of Neurology
Brief Communications

MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window

P. D. Mitsias, MD, M. Lu, PhD, B. Silver, MD, D. Morris, MD, J. R. Ewing, PhD, S. Daley, RN, C. Lewandowski, MD, A. Katramados, MD, N. I. Papamitsakis, MD, H. B. Ebadian, MS, Q. Zhao, MS, H. Soltanian-Zadeh, PhD, D. Hearshen, PhD, S. C. Patel, MD and M. Chopp, PhD

Departments of Neurology (Drs. Mitsias, Silver, Ewing, Katramados, and Chopp, S. Daley, H.B. Ebadian, and Q. Zhao) Biostatistics and Research Epidemiology (Dr. Lu), Emergency Medicine (Drs. Morris and Lewandowski), and Radiology (Drs. Ewing, Soltanian-Zadeh, Hearshen, and Patel, H.B. Ebadian and Q. Zhao), Henry Ford Health Sciences Center, Detroit, Michigan; New Jersey Neuroscience Institute (Dr. Papamitsakis), JFK Medical Center, Edison, New Jersey; Department of Medical Physics (Dr. Chopp), Oakland University, Rochester, Michigan.

Address correspondence and reprint requests to Dr. Panayiotis D. Mitsias, Department of Neurology, K-11, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202; e-mail: mitsias{at}neuro.hfh.edu

The authors assessed the effect of IV abciximab on early neurologic improvement and ischemic lesion growth in 29 patients with supratentorial stroke and NIH stroke scale score (NIHSSS) ≥ 4 (11.1 ± 5.9), treated within 3 to 24 (13.6 ± 5.5) hours of onset. The 48 to 72-hour NIHSSS improvement was 4.4 ± 3.2 and the 24-hour lesion growth on DWI was +23% (–50%, +103%); 7/26 (27%) patients experienced lesion size decrease. Treatment of sub-24-hour stroke with abciximab improves early post-treatment neurologic status and often attenuates ischemic lesion growth.

Supported by NIH/National Institute of Neurologic Disorders and Stroke grant PO1 NS 23393.

Disclosure: The authors report no conflicts of interest.

Received October 27, 2004. Accepted in final form May 9, 2005.


Related Article

August 23 Highlights
Neurology 2005 65: 504-505. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 CirculationHome page
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al.
Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Circulation, May 22, 2007; 115(20): e478 - e534.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. Alonso, A. Della Martina, M. Stroick, M. Fatar, M. Griebe, S. Pochon, M. Schneider, M. Hennerici, E. Allemann, and S. Meairs
Molecular Imaging of Human Thrombus With Novel Abciximab Immunobubbles and Ultrasound
Stroke, May 1, 2007; 38(5): 1508 - 1514.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al.
Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists
Stroke, May 1, 2007; 38(5): 1655 - 1711.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Mandava, J. A. Anderson, and T. A. Kent
MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window
Neurology, April 11, 2006; 66(7): 1132 - 1132.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

MRI-guided, open trial of abciximab for ischemic stroke within a 3- to 24-hour window
Pitchaiah Mandava, et al.
Neurology Online, 8 Nov 2005 [Full text]